Angiotension converting enzyme (ACE) inhibitors are medication type commonly used to lower blood pressure.
In a study presented at the recent Digestive Disease Week® 2006, researchers found that ACE inhibitors may be doing more that treating the patients’ hypertension but may be significantly decreasing their risk of developing three types of cancers: esophageal, pancreatic and colon.
Read more at EurekAlert."Our results call for further studies to investigate the promising benefits of ACE Inhibitors in cancer prevention," said Vikas Khurana, M.D., lead study author from the Overton Brooks VA Medical Center in Shreveport, LA. "Through confirmatory research we hope to shed light on the valuable role ACE inhibitors may play in advancing current treatment options for multiple cancers.
" Researchers believe the potential benefit of ACE Inhibitors against cancer may be due to the suppression of tumor angiogenesis by blocking a growth protein called VEGF (Vascular Endothelial Growth Factor), which is believed to play a significant role in the growth and reproduction of tumors.
Comment Preview